China on this Thursday on this Thursday announced that it has granted market approval attached with conditions for its first homemade COVID-19 vaccine, which was developed by Sinopharm, marking a monumental step in the battle against the pandemic that has killed 1.79 million globally.
Beijing Biological Products Institute announced that the vaccine showed 79.34 percent efficacy and a 99.52 percent antibody positive conversion rate, according to interim results of the Phase III clinical trials.
Subsequently, the persistence and protective effect of vaccine immunity need to be continuously observed.The hard-won achievement build confidence for the global fight against the epidemic and also provides strong support for vaccines to become a global public production.
Related Posts
International students in China commemorate Wuhan restart Anniversary
2021 Top 10 richest people in China, Jack Ma and Zhong shan Leading
Foreign Students in China Begin to receive Covid-19 Vaccines
Scholarships Stats of International Students in China in recent years!
Good news!Visa rules reduced for Chinese vaccine recipient in 26 countries